A

Alexion

Global biopharmaceuticals focusing on rare diseases

Market Access Contract Operations Specialist

Internal Audit & ControlsPosted on Nov 9
Full-timeBoston, MA, USA

About the Job

Requirements

  • At least 3 years of experience; a bachelor's degree in business, finance, accounting, healthcare administration, economics, or a related field is preferred, and equivalent relevant experience may be considered.
  • Experience in market access, government pricing, pharmaceutical contracting, SOX controls, or another regulated operational environment is preferred.
  • Proficiency in Microsoft Excel, Word, and PowerPoint is required; SAP experience is preferred.
  • Ability to use data validation, process documentation, and operational reporting.
  • Strong attention to detail, organizational skills, analytical thinking, and ability to manage multiple priorities in a compliance-focused environment.
  • Effective written and verbal communication and ability to collaborate across cross-functional teams and third-party vendors.
  • Ability to prioritize multiple payment types and process them timely and accurately.
  • Strong analytical, problem-solving, judgment, and decision-making skills.
  • Ability to work in a fast-paced team environment, manage workload to deadlines, and adapt to changing business requirements and processes.
  • Ability to perform office-based work, including computer use, phone/video/electronic communications, problem solving, collaboration, and general availability during standard business hours.

Responsibilities

  • Support identification, investigation, documentation, and timely resolution of market access operational disputes.
  • Follow established internal controls, maintain required documentation, and assist with periodic reviews to support SOX compliance and company policies.
  • Coordinate internal payment approvals and troubleshoot payment-related issues internally and externally.
  • Assist with vendor and customer system setup; validate and track vendor invoices against budget.
  • Support Tricare, VA IFF, and Government Pricing processes through data review, pricing and process coordination, checklists, reconciliations, and issue follow-up.
  • Prepare audit documentation, gather records, respond to information requests, and support internal and external audits, including remediation follow-up where applicable.
  • Partner with Government Pricing to review data inputs, assist with reconciliations, identify discrepancies, and confirm alignment of pricing-related operational processes with business and compliance requirements.
  • Support Inflation Reduction Act operational activities through data review, process coordination, and implementation efforts tied to evolving requirements.
  • Review contract-related information, identify trends or issues, and provide operational insights to support execution, compliance, and decision-making.
  • Maintain approved Executive Pricing Committee and Advanced Customer Engagement Review Team business case records regularly.
  • Maintain U.S. WAC Launch Price and U.S. WAC Price Change standard operating procedures; collaborate with cross-functional stakeholders on changes and ensure procedures remain current, accurate, and aligned with business and governance requirements.
  • Perform other duties as assigned.

Desired Qualifications

  • Experience in the pharmaceutical industry, with knowledge of commercial contracting and government price reporting.
  • Good working knowledge of contracting and rebate payment systems.
  • Demonstrated commitment to accuracy, documentation, internal controls, and process discipline.
  • Ability to work effectively with stakeholders across Market Access, Government Pricing, Finance, Compliance, and other relevant teams.
  • Ability to recognize issues, evaluate risks, and escalate exceptions in a timely manner.
  • Curiosity and willingness to learn evolving requirements related to Government Pricing, the Inflation Reduction Act, and U.S. Market Access operations.
  • Ability to handle sensitive commercial and pricing information with discretion and professionalism.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs